In contrast to the initialassumption of PPARγ mainly acting as a tumor suppressor whose activity and/or expression islost in cancers, PPARγ expression and activity can also be a negative predictor of canceraggressiveness; and positive cooperation between PPARγ and components of the ERK cascadein malignant phenotypes takes place. The gene discussed is MAPK1; the disease is cancer.